Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The effect of higher-intensity dosing of anticoagulation on the clinical outcomes in hospitalized patients with COVID-19: A meta-analysis of randomized controlled trials
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
Journal of Infection and Chemotherapy (2021) Vol. 28, Iss. 2, pp. 257-265
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Heparin: An old drug for new clinical applications
Peipei Wang, Lianli Chi, Zhenqing Zhang, et al.
Carbohydrate Polymers (2022) Vol. 295, pp. 119818-119818
Closed Access | Times Cited: 80
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients
Adam Cuker, Eric Tseng, Robby Nieuwlaat, et al.
Blood Advances (2022) Vol. 6, Iss. 17, pp. 4915-4923
Open Access | Times Cited: 56
The Effect of Heparin Full-Dose Anticoagulation on Survival of Hospitalized, Non-critically Ill COVID-19 Patients: A Meta-analysis of High Quality Studies
Eros Pilia, Alessandro Belletti, Stefano Fresilli, et al.
Lung (2023) Vol. 201, Iss. 2, pp. 135-147
Open Access | Times Cited: 10
The Role of Heparin in COVID-19: An Update after Two Years of Pandemics
Marco Mangiafico, Andrea Caff, Luca Costanzo
Journal of Clinical Medicine (2022) Vol. 11, Iss. 11, pp. 3099-3099
Open Access | Times Cited: 15
Pattern of medication utilization in hospitalized patients with COVID-19 in three District Headquarters Hospitals in the Punjab province of Pakistan
Zia Ul Mustafa, Chia Siang Kow, Muhammad Salman, et al.
Exploratory Research in Clinical and Social Pharmacy (2021) Vol. 5, pp. 100101-100101
Open Access | Times Cited: 16
Major Bleeding Events in Hospitalized COVID-19 Patients: A Retrospective Observational Study
Andrea Poloni, Giacomo Casalini, Giacomo Pozza, et al.
Medicina (2024) Vol. 60, Iss. 5, pp. 814-814
Open Access | Times Cited: 1
Multifaceted Heparin: Diverse Applications beyond Anticoagulant Therapy
Razia Sultana, Masamichi Kamihira
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1362-1362
Open Access | Times Cited: 1
Letter to the Editor: “Improving Risk Analysis for Fatal Thrombosis in COVID-19: A Call for Targeted Anticoagulation” regarding: “Incidence, Predictors, and Outcomes of Venous and Arterial Thrombosis in COVID-19: A Nationwide Inpatient Analysis” by Agrawal et al. Heart Lung Circ. 2024;33(11):1563–73
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan, et al.
Heart Lung and Circulation (2024) Vol. 33, Iss. 11, pp. e61-e62
Closed Access | Times Cited: 1
Anticoagulant Treatment in Severe ARDS COVID-19 Patients
Adrián Ceccato, Marta Camprubí‐Rimblas, Elena Campaña-Duel, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 10, pp. 2695-2695
Open Access | Times Cited: 8
Efficacy and safety of intensified versus standard prophylactic anticoagulation therapy in patients with Covid-19: a systematic review and meta-analysis
Nicola K Wills, Nikhil Nair, Kashyap Patel, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
Efficacy and Safety of Intensified Versus Standard Prophylactic Anticoagulation Therapy in Patients With Coronavirus Disease 2019: A Systematic Review and Meta-Analysis
Nicola K Wills, Nikhil Nair, Kashyap Patel, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 7
Open Access | Times Cited: 6
Failed clinical trials on COVID-19 acute respiratory distress syndrome in hospitalized patients: common oversights and streamlining the development of clinically effective therapeutics
Denise Battaglini, Fernanda F. Cruz, Chiara Robba, et al.
Expert Opinion on Investigational Drugs (2022) Vol. 31, Iss. 10, pp. 995-1015
Closed Access | Times Cited: 6
Intermediate dose enoxaparin in hospitalized patients with moderate-severe COVID-19: a pilot phase II single-arm study, INHIXACOVID19
Benilde Cosmi, Maddalena Giannella, G Fornaro, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Therapeutic-dose anticoagulation or thromboprophylaxis with low-molecular-weight heparin for moderate Covid-19: meta-analysis of randomized controlled trials
Javier Ena, Victoria Valls
Clinical and Experimental Medicine (2022) Vol. 23, Iss. 4, pp. 1189-1196
Open Access | Times Cited: 4
Psychometric evaluation and medication usage pattern in Covid-19 patients: A retrospective study
Surendhar Amargeeth, Vedha Pal Jeyamani, Santha Kumar, et al.
World Journal of Advanced Research and Reviews (2024) Vol. 21, Iss. 2, pp. 1034-1042
Open Access
COVID-19 and acute pulmonary embolism
Marco Zuin, Gianluca Rigatelli
Elsevier eBooks (2024), pp. 295-301
Closed Access
Reply to Letter to the Editor: “Risk Factors Associated With Fatal Thrombosis in COVID-19” regarding: “Improving Risk Analysis for Fatal Thrombosis in COVID-19: A Call for Targeted Anticoagulation”
Ankit Agrawal, Umesh Bhagat, Aro Daniela Arockiam, et al.
Heart Lung and Circulation (2024) Vol. 33, Iss. 11, pp. e63-e65
Closed Access
Anticoagulant Therapy in COVID-19 Associated Venous Thromboembolism: A Pivotal Risk Factor
Chia Siang Kow, Kaeshaelya Thiruchelvam
Angiology (2023) Vol. 75, Iss. 9, pp. 899-899
Open Access | Times Cited: 1
The Comparison of Therapeutic With Prophylactic Anticoagulation on Mortality, Risk of Bleeding, and Thromboembolism in Hospitalized Patients With COVID-19: A Systematic Review
Nang I Kham, Rabia Shahid, Shaili S Naik, et al.
Cureus (2022)
Open Access | Times Cited: 2
Hemin, erythropoietin and antithrombotics to treat Covid-19
Lianne Abrahams
(2022)
Open Access | Times Cited: 1
Higher Dose Anticoagulation Cannot Prevent Disease Progression in COVID-19 Patients: A Systematic Review and Meta-Analysis
Emőke Henrietta Kovács, Krisztián Tánczos, L. Szabó, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2194-2194
Open Access | Times Cited: 1
Antiporphyrics, antithrombotics and erythropoiesis stimulating agents to treat Covid-19: A living systematic review and meta-analysis
Lianne Abrahams
(2022)
Open Access | Times Cited: 1
Enoxaparin for COVID-19: a systematic review and meta-analysis of randomized controlled trials
Muhammad Ehsan, Uzair Jafar, Momina Butt, et al.
Journal of Thrombosis and Thrombolysis (2023) Vol. 56, Iss. 3, pp. 495-498
Closed Access
Embracing Imatinib: a novel approach to safeguarding the endothelial barrier in patients with COVID-19
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
Angiogenesis (2023) Vol. 26, Iss. 4, pp. 481-483
Closed Access
Reply to “Embracing imatinib: a novel approach to safeguarding the endothelial barrier in patients with COVID-19”
Xiaoming Wu, Jialan Shi
Angiogenesis (2023) Vol. 26, Iss. 4, pp. 485-486
Closed Access
Page 1 - Next Page

Scroll to top